Compound Profile: Norvasc 5 (30 pills) Pfizer
Norvasc 5 is a pharmaceutical preparation containing amlodipine besylate, a dihydropyridine calcium channel blocker compound developed by Pfizer. Amlodipine is a long-acting calcium channel antagonist that researchers study for its effects on vascular smooth muscle and cardiac tissue in laboratory investigations. This compound belongs to the dihydropyridine class of calcium channel blockers and serves as an important research tool for examining cardiovascular mechanisms, vascular reactivity, and calcium homeostasis in experimental models. Research teams at Stroid UK Shop utilise this pharmaceutical-grade preparation to investigate calcium channel physiology and vascular biology pathways.
Laboratory Applications
Research scientists examine Norvasc 5 in cardiovascular studies investigating calcium channel blockade mechanisms and vascular smooth muscle function. Laboratory investigations focus on amlodipine’s selective antagonism of L-type calcium channels in vascular tissues and its extended duration of action compared to other dihydropyridines. Researchers analyse this compound’s effects on arterial vasodilation, endothelial function, and calcium-dependent cellular processes in experimental models. Studies examine the compound’s pharmacokinetic properties, including its slow onset and long elimination half-life, making it valuable for sustained experimental protocols. Research teams also investigate amlodipine’s effects on oxidative stress pathways and nitric oxide signalling in cardiovascular research models, contributing to our understanding of calcium channel physiology. Investigators studying amlodipine research compounds examine these mechanisms alongside studies of selective androgen receptor modulators and research peptides in comprehensive laboratory investigations.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Amlodipine Besylate |
| Strength Per Tablet | 5mg |
| Quantity | 30 tablets |
| Manufacturer | Pfizer |
| Formulation | Pharmaceutical tablets |
| CAS Number | 111470-99-6 |
| Molecular Formula | C₂₀H₂₅ClN₂O₅·C₇H₈O₃S |
| Storage Requirements | Room temperature, dry conditions |
Research Compliance
Norvasc 5 tablets are supplied exclusively for in-vitro laboratory research and analytical purposes only. This pharmaceutical preparation is not intended for human consumption, therapeutic use, or any form of in-vivo application. Research institutions must ensure proper protocols for handling pharmaceutical compounds and maintain appropriate documentation for laboratory use. Investigators should verify compound specifications and implement suitable analytical methods for their specific research applications.
